Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hepatic lipopolysaccharide binding protein partially uncouples inflammation from fibrosis in MAFLD
Dan Wang, … , Jihane N. Benhammou, Tamer Sallam
Dan Wang, … , Jihane N. Benhammou, Tamer Sallam
Published July 26, 2024
Citation Information: J Clin Invest. 2024;134(17):e179752. https://doi.org/10.1172/JCI179752.
View: Text | PDF
Research Letter Genetics Hepatology

Hepatic lipopolysaccharide binding protein partially uncouples inflammation from fibrosis in MAFLD

  • Text
  • PDF
Abstract

Authors

Dan Wang, Ania Baghoomian, Zhengyi Zhang, Ya Cui, Emily C. Whang, Xiang Li, Josue Fraga, Rachel Ariana Spellman, Tien S. Dong, Wei Li, Arpana Gupta, Jihane N. Benhammou, Tamer Sallam

×

Figure 1

Hepatic LBP deficiency reduces inflammation but not fibrosis.

Options: View larger image (or click on image) Download as PowerPoint
Hepatic LBP deficiency reduces inflammation but not fibrosis.
(A–C) Seru...
(A–C) Serum LBP as indicated. (n = 5–8 in A, n = 5 in B, and n = 10 in C). (D) Liver H&E, Masson’s trichrome and Sirius red staining (arrows indicate inflammatory cells). (E) Quantification of inflammatory cells and fibrosis. (F) Liver lipidomics heatmap. (G and H) RT-qPCR from liver. (I) Liver IHC, scale bar: 100 μm. (J) Serum ALT/AST. (n = 8–9 in E–J). (K and L) UMAP plot and population annotation of snRNA-seq from liver. (M) Representative genes from the Immune 2 cluster. (N) RNA-Seq from human liver. (O) Correlation between circulating LBP and serum IL15RA in human MASH cohort. Data represent mean ± SEM. P value calculated by unpaired 2-tailed t-test (B, C, and E); 1-way ANOVA (A, I, J, and N); and 2-way ANOVA (G and H). *P < 0.05; **P < 0.01; ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts